#Properties section
SET DOCUMENT Name = "NDEx query result in BEL script"
SET DOCUMENT Description = "Query with ndex-python-client, one step neighborhood"

# Definitions Section
DEFINE NAMESPACE MESHD AS URL "http://resource.belframework.org/belframework/1.0/namespace/mesh-diseases.belns"
DEFINE NAMESPACE SDIS AS URL "http://resource.belframework.org/belframework/1.0/namespace/selventa-legacy-diseases.belns"
DEFINE NAMESPACE MESHCL AS URL "http://resource.belframework.org/belframework/1.0/namespace/mesh-cellular-locations.belns"
DEFINE NAMESPACE RGD AS URL "http://resource.belframework.org/belframework/1.0/namespace/rgd-approved-symbols.belns"
DEFINE NAMESPACE MESHPP AS URL "http://resource.belframework.org/belframework/1.0/namespace/mesh-biological-processes.belns"
DEFINE NAMESPACE SCHEM AS URL "http://resource.belframework.org/belframework/1.0/namespace/selventa-legacy-chemical-names.belns"
DEFINE NAMESPACE EGID AS URL "http://resource.belframework.org/belframework/1.0/namespace/entrez-gene-ids-hmr.belns"
DEFINE NAMESPACE GO AS URL "http://resource.belframework.org/belframework/1.0/namespace/go-biological-processes-names.belns"
DEFINE NAMESPACE CHEBIID AS URL "http://resource.belframework.org/belframework/1.0/namespace/chebi-ids.belns"
DEFINE NAMESPACE PFH AS URL "http://resource.belframework.org/belframework/1.0/namespace/selventa-named-human-protein-families.belns"
DEFINE NAMESPACE NCR AS URL "http://resource.belframework.org/belframework/1.0/namespace/selventa-named-rat-complexes.belns"
DEFINE NAMESPACE PFM AS URL "http://resource.belframework.org/belframework/1.0/namespace/selventa-named-mouse-protein-families.belns"
DEFINE NAMESPACE SPAC AS URL "http://resource.belframework.org/belframework/1.0/namespace/swissprot-accession-numbers.belns"
DEFINE NAMESPACE NCH AS URL "http://resource.belframework.org/belframework/1.0/namespace/selventa-named-human-complexes.belns"
DEFINE NAMESPACE NCM AS URL "http://resource.belframework.org/belframework/1.0/namespace/selventa-named-mouse-complexes.belns"
DEFINE NAMESPACE CHEBI AS URL "http://resource.belframework.org/belframework/1.0/namespace/chebi-names.belns"
DEFINE NAMESPACE MGI AS URL "http://resource.belframework.org/belframework/1.0/namespace/mgi-approved-symbols.belns"
DEFINE NAMESPACE HGNC AS URL "http://resource.belframework.org/belframework/1.0/namespace/hgnc-approved-symbols.belns"
DEFINE NAMESPACE PFR AS URL "http://resource.belframework.org/belframework/1.0/namespace/selventa-named-rat-protein-families.belns"
DEFINE ANNOTATION EndocrineSystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-endocrine-system.belanno"
DEFINE ANNOTATION RespiratorySystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-respiratory-system.belanno"
DEFINE ANNOTATION IntegumentarySystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-integumentary-system.belanno"
DEFINE ANNOTATION BodyRegion AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-body-region.belanno"
DEFINE ANNOTATION Cell AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-cell.belanno"
DEFINE ANNOTATION UrogenitalSystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-urogenital-system.belanno"
DEFINE ANNOTATION MuskuloskeletalSystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-musculoskeletal-system.belanno"
DEFINE ANNOTATION HemicAndImmuneSystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-hemic-and-immune-system.belanno"
DEFINE ANNOTATION CellLine AS URL "http://resource.belframework.org/belframework/1.0/annotation/atcc-cell-line.belanno"
DEFINE ANNOTATION SenseOrgan AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-sense-organ.belanno"
DEFINE ANNOTATION FluidAndSecretion AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-fluid-and-secretion.belanno"
DEFINE ANNOTATION CardiovascularSystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-cardiovascular-system.belanno"
DEFINE ANNOTATION Disease AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-disease.belanno"
DEFINE ANNOTATION CellStructure AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-cell-structure.belanno"
DEFINE ANNOTATION NervousSystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-nervous-system.belanno"
DEFINE ANNOTATION Species AS URL "http://resource.belframework.org/belframework/1.0/annotation/species-taxonomy-id.belanno"
DEFINE ANNOTATION Tissue AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-tissue.belanno"
DEFINE ANNOTATION DigestiveSystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-digestive-system.belanno"

#Statements section

SET STATEMENT_GROUP = "Group pmid:15225871"
SET Citation = {"PubMed","Gene","15225871"}


SET Evidence = "The binding of RB, p107, or p130 has two simultaneous consequences: (1) binding prevents E2F from interacting with transcriptional co-activators (e.g., p300);"

complexabundance(proteinabundance(HGNC:RB1),proteinabundance(PFH:E2F Family)) directlyDecreases complexabundance(proteinabundance(PFH:E2F Family),proteinabundance(HGNC:EP300))
complexabundance(proteinabundance(HGNC:RBL1),proteinabundance(PFH:E2F Family)) directlyDecreases complexabundance(proteinabundance(PFH:E2F Family),proteinabundance(HGNC:EP300))
complexabundance(proteinabundance(HGNC:RBL2),proteinabundance(PFH:E2F Family)) directlyDecreases complexabundance(proteinabundance(PFH:E2F Family),proteinabundance(HGNC:EP300))

SET Evidence = "RB and the related family members p107 and p130 can each bind E2F to repress genes that are otherwise important for progression from G1 to S phase."

complexabundance(proteinabundance(HGNC:RBL2),proteinabundance(PFH:E2F Family)) decreases biologicalprocess(GO:G1/S transition of mitotic cell cycle)

UNSET STATEMENT_GROUP

SET STATEMENT_GROUP = "Group pmid:15917664"
SET Citation = {"PubMed","Cell cycle (Georgetown, Tex.)","15917664"}


SET Evidence = "Nuclear import triggered by oxidative stress results in association of FOXO proteins with proteins that have histone acetylase activity, such as p300/CBP and p300/CBP-associated factor (PCAF)."

biologicalprocess(GO:response to oxidative stress) increases complexabundance(proteinabundance(PFH:FOXO Family),proteinabundance(HGNC:EP300))

SET Evidence = "Akt-dependent phosphorylation reduces the DNA-binding activity of FOXO, interferes with binding to the co-activators p300/CBP, and inactivates the FOXO nuclear translocation signal"

kinaseactivity(proteinabundance(HGNC:AKT1)) decreases complexabundance(proteinabundance(HGNC:AKT1),proteinabundance(HGNC:EP300))

UNSET STATEMENT_GROUP

SET STATEMENT_GROUP = "Group pmid:15350900"
SET Citation = {"PubMed","Trends in molecular medicine","15350900"}


SET Evidence = "In a second hydroxylation-dependent control, b-hydroxylation of an asparaginyl residue in the C-terminal activation domain of HIF-a (N803 in human HIF-1a) is regulated by a HIF asparaginyl hydroxylase called FIH (factor inhibiting HIF) [62,63]. Hydroxylation at this site prevents the binding of the transcriptional co-activators p300/CBP (CREB binding protein). Under normoxic conditions, these hydroxylation reactions provide a dual mechanism for HIF inactivation that involves proteolytic destruction and the inhibition of transcriptional activity [64]."

proteinabundance(HGNC:HIF1A,proteinmodification(H,N,803)) directlyDecreases complexabundance(proteinabundance(HGNC:HIF1A),proteinabundance(HGNC:EP300))
complexabundance(proteinabundance(HGNC:HIF1A),proteinabundance(HGNC:EP300)) directlyIncreases transcriptionalactivity(proteinabundance(HGNC:HIF1A))

UNSET STATEMENT_GROUP

SET STATEMENT_GROUP = "Group pmid:19151761"
SET Citation = {"PubMed","Oncogene","19151761"}


SET Evidence = "In addition, loss of function of the pRb family member p130 may be part of tumor progression in several types of human cancers, including lung adenocarcinomas (Claudio et al., 2000; Cinti et al., 2005), but a causal role for loss of p130 in lung cancer progression also remains to be determined. "

proteinabundance(HGNC:RBL2) negativeCorrelation pathology(MESHD:Adenocarcinoma)

UNSET STATEMENT_GROUP

SET STATEMENT_GROUP = "Group pmid:12778166"
SET Citation = {"PubMed","Nature medicine","12778166"}


SET Evidence = "In a second hydroxylation-dependent control, beta-hydroxylation of an asparaginyl residue in the C-terminal activation domain of HIF-alpha (Asn803 in human HIF-1alpha)35 is regulated by a HIF asparaginyl hydroxylase33, 36 termed FIH (factor inhibiting HIF)37. Hydroxylation at this site blocks interaction of the HIF-alpha C-terminal activation domain with the transcriptional coactivator p300. "

proteinabundance(HGNC:HIF1A,proteinmodification(H,N,803)) directlyDecreases complexabundance(proteinabundance(HGNC:HIF1A),proteinabundance(HGNC:EP300))

UNSET STATEMENT_GROUP
